4.7 Article

Design and Discovery of Functionally Selective Serotonin 2C (5-HT2c) Receptor Agonists

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 59, 期 21, 页码 9866-9880

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b01194

关键词

-

资金

  1. National Institute of Mental Health (NIMH) [R01MH99993]
  2. Psychoactive Drug Screening Program (PDSP) [HHSN-271-2013-00017-C]

向作者/读者索取更多资源

On the basis of the structural similarity of our previous 5-HT2c agonists with the melatonin receptor agonist tasimelteon and the putative biological cross-talk between serotonergic and melatonergic systems, a series of new (2,3-dihydro)benzofuran-based compounds were designed and synthesized. The compounds were evaluated for their selectivity toward 5-HT2A, 5-HT2B, and 5HT(2c) receptors in the calcium flux assay with the ultimate goal to generate selective 5-HT2c agonists. Selected compounds were studied for their functional selectivity by comparing their transduction efficiency at the G protein signaling pathway versus beta-arrestin recruitment. The most functionally selective compound (+)-7e produced weak beta-arrestin recruitment and also demonstrated less receptor desensitization compared to serotonin in both calcium flux and phosphoinositide (PI) hydrolysis assays. We report for the first time that selective 5-HT2c agonists possessing weak beta-arrestin recruitment can produce distinct receptor desensitization properties.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Virtual discovery of melatonin receptor ligands to modulate circadian rhythms

Reed M. Stein, Hye Jin Kang, John D. McCorvy, Grant C. Glatfelter, Anthony J. Jones, Tao Che, Samuel Slocum, Xi-Ping Huang, Olena Savych, Yurii S. Moroz, Benjamin Stauch, Linda C. Johansson, Vadim Cherezov, Terry Kenakin, John J. Irwin, Brian K. Shoichet, Bryan L. Roth, Margarita L. Dubocovich

NATURE (2020)

Editorial Material Multidisciplinary Sciences

A self-activating orphan receptor

Brian Krumm, Bryan L. Roth

NATURE (2020)

Article Neurosciences

Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys

Yuji Nagai, Naohisa Miyakawa, Hiroyuki Takuwa, Yukiko Hori, Kei Oyama, Bin Ji, Manami Takahashi, Xi-Ping Huang, Samuel T. Slocum, Jeffrey F. DiBerto, Yan Xiong, Takuya Urushihata, Toshiyuki Hirabayashi, Atsushi Fujimoto, Koki Mimura, Justin G. English, Jing Liu, Ken-ichi Inoue, Katsushi Kumata, Chie Seki, Maiko Ono, Masafumi Shimojo, Ming-Rong Zhang, Yutaka Tomita, Jin Nakahara, Tetsuya Suhara, Masahiko Takada, Makoto Higuchi, Jian Jin, Bryan L. Roth, Takafumi Minamimoto

NATURE NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Differential Roles of Extracellular Histidine Residues of GPR68 for Proton-Sensing and Allosteric Modulation by Divalent Metal Ions

Xi-Ping Huang, Terrence P. Kenakin, Shuo Gu, Brian K. Shoichet, Bryan L. Roth

BIOCHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

Kuglae Kim, Tao Che, Ouliana Panova, Jeffrey F. DiBerto, Jiankun Lyu, Brian E. Krumm, Daniel Wacker, Michael J. Robertson, Alpay B. Seven, David E. Nichols, Brian K. Shoichet, Georgios Skiniotis, Bryan L. Roth

Article Chemistry, Medicinal

Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis

Wenwen Duan, Ying Sun, Meng Wu, Zhiyuan Zhang, Taotao Zhang, Huan Wang, Fei Li, Lingyun Yang, Yueming Xu, Zhi-Jie Liu, Tian Hua, Hong Nie, Jianjun Cheng

Summary: The study focused on designing and synthesizing novel cannabinoids based on the structural backbones of THC and CBD, showing improved metabolic stability and good in vivo pharmacokinetic profiles. Compounds 15b and 38b exhibited significant alleviation of experimental autoimmune encephalomyelitis in mice, indicating potential therapeutic effects.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

2-Phenylcyclopropylmethylamine Derivatives as Dopamine D2 Receptor Partial Agonists: Design, Synthesis, and Biological Evaluation

Wenzhong Yan, Luyu Fan, Jing Yu, Ruiquan Liu, Huan Wang, Liang Tan, Sheng Wang, Jianjun Cheng

Summary: The novel compounds based on PCPMA scaffold were designed and synthesized, resulting in the identification of potent D2R partial agonists with good pharmacokinetic properties and unexpected selectivity against the 5-HT2A receptor. These PCPMA-derived D2R partial agonists showed suppressive effects in a mouse hyperlocomotion model, indicating their potential as novel antipsychotics.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents

Wenzhong Yan, Lijun Ling, Yiran Wu, Kexin Yang, Ruiquan Liu, Jinfeng Zhang, Simeng Zhao, Guisheng Zhong, Suwen Zhao, Hualiang Jiang, Chengying Xie, Jianjun Cheng

Summary: Adenosine serves as an immunosuppressive factor in the tumor microenvironment by activating the A(2A) adenosine receptor. Dual-acting compounds targeting A(2A)R and HDAC are potentially effective immunotherapeutic agents that show promising antitumor activity in vitro and in vivo.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Neurosciences

Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties

Zhangcheng Chen, Luyu Fan, Huan Wang, Jing Yu, Dengyu Lu, Jianzhong Qi, Fen Nie, Zhipu Luo, Zhen Liu, Jianjun Cheng, Sheng Wang

Summary: Third-generation antipsychotic drugs (TGAs) have unique pharmacological properties that can improve cognition and potential antidepressant effects by targeting dopamine and serotonin receptors. By analyzing the structures of TGAs and 5-HT2AR, novel drugs with potent antipsychotic, antidepressant, and cognitive-enhancing properties can be designed.

NATURE NEUROSCIENCE (2022)

Article Chemistry, Medicinal

Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin V2 Receptor in In Vitro, Ex Vivo, and In Vivo Models of ADPKD

Xiaoke Gu, Haoxing Yuan, Wenchao Zhao, Nan Sun, Wenzhong Yan, Chunyu Jiang, Yan He, Hongli Liu, Jianjun Cheng, Dong Guo

Summary: This study aimed to design a photoswitchable ligand for precise control of ligand-receptor residence time and its pharmacological activity.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Transformation of a Dopamine D2 Receptor Agonist to Partial Agonists as Novel Antipsychotic Agents

Ruiquan Liu, Jianzhong Qi, Huan Wang, Luyu Fan, Pei Zhang, Jing Yu, Liang Tan, Sheng Wang, Jianjun Cheng

Summary: Designed ligands of G protein-coupled receptors can have various modulating effects, including full agonist, partial agonist, antagonist, and inverse agonist. Partial agonist activity is the pharmacological feature of third-generation antipsychotics for the dopamine D2 receptor (D2R). A series of D2R partial agonists were designed and synthesized based on a benzofuran-derived D2R full agonist. Compound 10b showed excellent activity, and further optimizations led to the discovery of brain-penetrant compounds 29c and 29d with potent antipsychotic effects.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Adenosine A2A Receptor (A2AAR) Ligand Screening Using the 19F-NMR Probe FPPA

Jinfeng Zhang, Dandan Feng, Jianjun Cheng, Kurt Wuthrich

Summary: The binding affinity of G protein-coupled receptor (GPCR) ligands is usually measured by radio-ligand competition experiments. Alternatively, F-19 nuclear magnetic resonance spectroscopy (F-19-NMR) is used for screening small-molecule lead compounds in drug discovery. A fluorine-containing probe molecule, FPPA, was designed based on the structure of the A(2A) adenosine receptor (A(2A)AR) complex with V-2006. The F-19-NMR with FPPA is a robust approach for discovering ligands with new core structures.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Chemistry, Medicinal

Design and Synthesis of Novel GPR139 Agonists with Therapeutic Effects in Mouse Models of Social Interaction and Cognitive Impairment

Jianhang Mao, Yilong Cui, Huan Wang, Wenwen Duan, Zhi-Jie Liu, Tian Hua, Ning Zhou, Jianjun Cheng

Summary: This study optimized the GPR139 agonist TAK-041 and synthesized new compounds, evaluating their activity at the GPR139 receptor. The compounds showed potential therapeutic effects on schizophrenia symptoms in murine models. Compound 20a exhibited the best activity and pharmacokinetic properties, making it a promising candidate as an antischizophrenia drug.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin V2 Receptor in In Vitro, Ex Vivo, and In Vivo Models of ADPKD

Xiaoke Gu, Haoxing Yuan, Wenchao Zhao, Nan Sun, Wenzhong Yan, Chunyu Jiang, Yan He, Hongli Liu, Jianjun Cheng, Dong Guo

Summary: This article introduces a method for controlling the residence time of a ligand with its receptor using photo-switching technology. The researchers designed a photo-switchable ligand targeting the vasopressin V2 receptor, which can prolong the binding time with the receptor upon irradiation. The experimental results show that this photo-switchable ligand can have different inhibitory effects on cellular function and exhibits different efficacy in inhibiting renal cystogenesis both in vitro and in vivo.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

The activities of drug inactive ingredients on biological targets

Joshua Pottel, Duncan Armstrong, Ling Zou, Alexander Fekete, Xi-Ping Huang, Hayarpi Torosyan, Dallas Bednarczyk, Steven Whitebread, Barun Bhhatarai, Guiqing Liang, Hong Jin, S. Nassir Ghaemi, Samuel Slocum, Katalin V. Lukacs, John J. Irwin, Ellen L. Berg, Kathleen M. Giacomini, Bryan L. Roth, Brian K. Shoichet, Laszlo Urban

SCIENCE (2020)

暂无数据